Products

What will AGI do for Bismuth subsalicylate?

This classification denotes a cytoprotective agent and antidiarrheal agent with the molecular formula C7H4O3.Bi.HO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 62TEY51RR1, chemically known as salicylic acid, bismuth(3+) salt (3:1) but generally known as bismuth salicylate, which bears US NIH Compound Identifier 197976. European Medicines Agency schedules Bismuth subsalicylate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13093MIG. As of Q4 2014, BISMUTH SUBSALICYLATE remains the US FDA Preferred Term for this commodity. Bismuth subsalicylate bears US NLM identifiers UMLS ID C0053792 and NCI Concept Code C1020. SMILES: C1=CC=C2C(=C1)C(=O)O[Bi]O2.O.

How AGI delivers it

Four ways AGI delivers for Bismuth subsalicylate

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Bismuth subsalicylate, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Bismuth subsalicylate, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Bismuth subsalicylate connects

measured by

  • Bismuth Assaymodel
  • Heavy Metal Contentmodel
  • Loss On Dryingmodel
  • Particle Size Distributionmodel
  • Salicylate Contentmodel
  • Salicylic Acid Contentmodel